| Patent | Date |
|---|
Jak Kinase Inhibitor Compounds For Treatment Of Respiratory Disease
App 20220306624 - Fatheree; Paul R. ; et al. | 2022-09-29 |
Compounds and methods for modulating Bruton's Tyrosine Kinase
Grant 11,306,099 - Hudson , et al. April 19, 2 | 2022-04-19 |
JAK kinase inhibitor compounds for treatment of respiratory disease
Grant 11,299,492 - Fatheree , et al. April 12, 2 | 2022-04-12 |
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
App 20220017485 - Beausoleil; Anne-Marie ; et al. | 2022-01-20 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20210401808 - Fleury; Melissa ; et al. | 2021-12-30 |
Killing Senescent Cells And Treating Senescence-Associated Conditions Using A Bcl Inhibitor And An Mcl-1 Inhibitor
App 20210379078 - Kwak; Pieter Bas ; et al. | 2021-12-09 |
Pyrimidine compounds as JAK kinase inhibitors
Grant 11,110,095 - Hudson , et al. September 7, 2 | 2021-09-07 |
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid
Grant 11,033,533 - Fleury , et al. June 15, 2 | 2021-06-15 |
Compounds and methods for modulating interleukin-2-inducible t-cell kinase
Grant 11,008,314 - Hudson , et al. May 18, 2 | 2021-05-18 |
Jak Kinase Inhibitor Compounds For Treatment Of Respiratory Disease
App 20210130351 - Fatheree; Paul R. ; et al. | 2021-05-06 |
Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
Grant 10,981,892 - Beausoleil , et al. April 20, 2 | 2021-04-20 |
Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
App 20210070788 - Beausoleil; Anne-Marie ; et al. | 2021-03-11 |
Phosphonamidates that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
App 20200399259 - Beausoleil; Anne-Marie ; et al. | 2020-12-24 |
Compounds and methods for modulating bruton's tyrosine kinase
Grant 10,870,652 - Hudson , et al. December 22, 2 | 2020-12-22 |
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
App 20200392105 - Beausoleil; Anne-Marie ; et al. | 2020-12-17 |
Inhibitors of HSP90, PI3-Kinase, Proteasome, HDAC, and P97 Pathways for Selective Removal of Senescent Cells in the Treatment of Age Related Conditions
App 20200360386 - Hudson; Ryan ; et al. | 2020-11-19 |
Treatment of Lung Diseases Using Pharmaceutical Agents that Eliminate Senescent Cells
App 20200354336 - Vlahakis; Nick ; et al. | 2020-11-12 |
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
App 20200317640 - Beausoleil; Anne-Marie ; et al. | 2020-10-08 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20200281900 - Fleury; Melissa ; et al. | 2020-09-10 |
Phospholidines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
Grant 10,745,429 - Beausoleil , et al. A | 2020-08-18 |
Phosphonamidates that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
Grant 10,738,042 - Beausoleil , et al. A | 2020-08-11 |
Acyl sulfonamides that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
Grant 10,717,722 - Beausoleil , et al. | 2020-07-21 |
Acyl phosphonamidates and acyl benzylamines that are Bcl family antagonists for use in clinical management of conditions caused or mediated by senescent cells and for treating cancer
Grant 10,703,745 - Beausoleil , et al. | 2020-07-07 |
Treatment of Lung Diseases Using Pharmaceutical Agents that Eliminate Senescent Cells
App 20200199103 - Vlahakis; Nick ; et al. | 2020-06-25 |
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
Grant 10,689,416 - Hudson , et al. | 2020-06-23 |
Pyrimidine Compounds As Jak Kinase Inhibitors
App 20200046709 - Hudson; Ryan ; et al. | 2020-02-13 |
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid
Grant 10,548,879 - Fleury , et al. Fe | 2020-02-04 |
JAK kinase inhibitor compounds for treatment of respiratory disease
Grant 10,526,330 - Fatheree , et al. J | 2020-01-07 |
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
App 20200002378 - Hudson; Ryan ; et al. | 2020-01-02 |
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
Grant 10,519,197 - Hudson , et al. Dec | 2019-12-31 |
Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent C
App 20190382371 - Beausoleil; Anne-Marie ; et al. | 2019-12-19 |
Compounds And Methods For Modulating Interleukin-2-inducible T-cell Kinase
App 20190375743 - HUDSON; Ryan ; et al. | 2019-12-12 |
Acyl Phosphonamidates and Acyl Benzylamines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused
App 20190367496 - Beausoleil; Anne-Marie ; et al. | 2019-12-05 |
Phosphonamidates that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating Cancer
App 20190330199 - Beausoleil; Anne-Marie ; et al. | 2019-10-31 |
Phospholidines that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cell
App 20190330250 - Beausoleil; Anne-Marie ; et al. | 2019-10-31 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20190269659 - Fleury; Melissa ; et al. | 2019-09-05 |
Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
App 20190248837 - Hudson; Ryan ; et al. | 2019-08-15 |
Compounds And Methods For Modulating Bruton's Tyrosine Kinase
App 20190106423 - HUDSON; Ryan ; et al. | 2019-04-11 |
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
App 20190106420 - Fatheree; Paul R. ; et al. | 2019-04-11 |
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid
Grant 10,172,834 - Fleury , et al. J | 2019-01-08 |
JAK kinase inhibitor compounds for treatment of respiratory disease
Grant 10,100,049 - Fatheree , et al. October 16, 2 | 2018-10-16 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20180228774 - Fleury; Melissa ; et al. | 2018-08-16 |
Pyrimidine compounds as JAK kinase inhibitors
Grant 10,028,960 - Hudson , et al. July 24, 2 | 2018-07-24 |
Neprilysin Inhibitors
App 20180193338 - Fleury; Melissa ; et al. | 2018-07-12 |
Neprilysin inhibitors
Grant 10,005,740 - Fleury , et al. June 26, 2 | 2018-06-26 |
Neprilysin Inhibitors
App 20180118696 - Fleury; Melissa ; et al. | 2018-05-03 |
(2R,4R)-5-(5'-Chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid
Grant 9,872,855 - Fleury , et al. January 23, 2 | 2018-01-23 |
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xymethyl-2-methylpentanoic acid
Grant 9,868,698 - Hughes , et al. January 16, 2 | 2018-01-16 |
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid
App 20170355665 - Hughes; Adam D. ; et al. | 2017-12-14 |
Pyrimidine Compounds As Jak Kinase Inhibitors
App 20170312280 - Hudson; Ryan ; et al. | 2017-11-02 |
Substituted naphthyridines as JAK kinase inhibitors
Grant 9,725,470 - Hudson , et al. August 8, 2 | 2017-08-08 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20170196841 - Fleury; Melissa ; et al. | 2017-07-13 |
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xmethyl-2-methylpentanoic acid
Grant 9,670,143 - Hughes , et al. June 6, 2 | 2017-06-06 |
JAK Kinase Inhibitor Compounds for Treatment of Respiratory Disease
App 20170121327 - Fatheree; Paul R. ; et al. | 2017-05-04 |
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid
App 20170088508 - Hughes; Adam D. ; et al. | 2017-03-30 |
(2R,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic acid
Grant 9,533,962 - Fleury , et al. January 3, 2 | 2017-01-03 |
Naphthyridine Compounds As Jak Kinase Inhibitors
App 20160347772 - Hudson; Ryan ; et al. | 2016-12-01 |
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xymethyl-2-methylpentanoic acid
Grant 9,433,598 - Hughes , et al. September 6, 2 | 2016-09-06 |
(2r,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole- -2-carbonyl)amino]pentanoic Acid
App 20160244416 - Fleury; Melissa ; et al. | 2016-08-25 |
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid
App 20160228395 - Hughes; Adam D. ; et al. | 2016-08-11 |
| 